{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T07:04:22Z","timestamp":1763535862992},"reference-count":9,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,5,1]]},"DOI":"10.7759\/cureus.14796","type":"journal-article","created":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T19:47:55Z","timestamp":1619898475000},"source":"Crossref","is-referenced-by-count":7,"title":["Alpelisib-Induced Diabetic Ketoacidosis"],"prefix":"10.7759","author":[{"given":"Paul","family":"Nguyen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aya","family":"Musa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julie","family":"Samantray","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6712a3","article-title":"Trends in diabetic ketoacidosis hospitalizations and in-hospital mortality - United States, 2000-2014","volume":"67","author":"Benoit SR","year":"2018","unstructured":"Benoit SR, Zhang Y, Geiss LS, Gregg EW, Albright A. Trends in diabetic ketoacidosis hospitalizations and in-hospital mortality - United States, 2000-2014. MMWR Morb Mortal Wkly Rep. 2018, 67:362-5. 10.15585\/mmwr.mm6712a3","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"ref2","unstructured":"Female breast cancer \u2014 cancer stat facts. (2021). Accessed. March 1, 2021: https:\/\/seer.cancer.gov\/statfacts\/html\/breast.html."},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.31921","article-title":"Phosphatidylinositol 3-kinase pathway genomic alterations in 60,991 diverse solid tumors informs targeted therapy opportunities","volume":"125","author":"Millis SZ","year":"2019","unstructured":"Millis SZ, Jardim DL, Albacker L, Ross JS, Miller VA, Ali SM, Kurzrock R. Phosphatidylinositol 3-kinase pathway genomic alterations in 60,991 diverse solid tumors informs targeted therapy opportunities. Cancer. 2019, 125:1185-99. 10.1002\/cncr.31921","journal-title":"Cancer"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2017.04.001","article-title":"AKT\/PKB signaling: navigating the network","volume":"169","author":"Manning BD","year":"2017","unstructured":"Manning BD, Toker A. AKT\/PKB signaling: navigating the network. Cell. 2017, 169:381-405. 10.1016\/j.cell.2017.04.001","journal-title":"Cell"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.7150\/ijbs.27173","article-title":"The PI3K\/AKT pathway in obesity and type 2 diabetes","volume":"14","author":"Huang X","year":"2018","unstructured":"Huang X, Liu G, Guo J, Su Z. The PI3K\/AKT pathway in obesity and type 2 diabetes. Int J Biol Sci. 2018, 14:1483-96. 10.7150\/ijbs.27173","journal-title":"Int J Biol Sci"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2007.03.006","article-title":"The GLUT4 glucose transporter","volume":"5","author":"Huang S","year":"2007","unstructured":"Huang S, Czech MP. The GLUT4 glucose transporter. Cell Metab. 2007, 5:237-52. 10.1016\/j.cmet.2007.03.006","journal-title":"Cell Metab"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1172\/JCI20016","article-title":"Defective insulin secretion and increased susceptibility to experimental diabetes are induced by reduced Akt activity in pancreatic islet beta cells","volume":"114","author":"Bernal-Mizrachi E","year":"2004","unstructured":"Bernal-Mizrachi E, Fatrai S, Johnson JD, et al.. Defective insulin secretion and increased susceptibility to experimental diabetes are induced by reduced Akt activity in pancreatic islet beta cells. J Clin Invest. 2004, 114:928-36. 10.1172\/JCI20016","journal-title":"J Clin Invest"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-018-0343-4","article-title":"Suppression of insulin feedback enhances the efficacy of PI3K inhibitors","volume":"560","author":"Hopkins BD","year":"2018","unstructured":"Hopkins BD, Pauli C, Du X, et al.. Suppression of insulin feedback enhances the efficacy of PI3K inhibitors. Nature. 2018, 560:499-503. 10.1038\/s41586-018-0343-4","journal-title":"Nature"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1813904","article-title":"Alpelisib for PIK3CA-mutated, hormone receptor-positive advanced breast cancer","volume":"380","author":"Andr\u00e9 F","year":"2019","unstructured":"Andr\u00e9 F, Ciruelos E, Rubovszky G, et al.. Alpelisib for PIK3CA-mutated, hormone receptor-positive advanced breast cancer. N Engl J Med. 2019, 380:1929-40. 10.1056\/NEJMoa1813904","journal-title":"N Engl J Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/56547-alpelisib-induced-diabetic-ketoacidosis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:32:48Z","timestamp":1707507168000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/56547-alpelisib-induced-diabetic-ketoacidosis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,1]]},"references-count":9,"URL":"https:\/\/doi.org\/10.7759\/cureus.14796","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5,1]]}}}